Scienmag

APRIL 16, 2021

– April 16, 2021 – Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Credit: Dotted Yeti LA JOLLA, CALIF.

Gene 60

Gene Scientist Research Allergies 60

Scienmag

JUNE 1, 2021

Army scientists working as part of an international consortium have developed and tested an antibody-based therapy to treat Crimean-Congo hemorrhagic fever virus (CCHFV), which is carried by ticks and kills up to 60 percent of those infected. Their results are published online today in the journal Cell.

Scientist 57

Scientist Development Antibody Allergies 57

Scienmag

SEPTEMBER 4, 2020

Anticholinergic medications are used for many conditions but might also accelerate cognitive decline, especially in older persons with biological or genetic risk factors A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies (..)

Allergies 41

Allergies Drugs Genetics Scientist 41

pharmaphorum

NOVEMBER 11, 2022

Marc Pelletier , Senior Principal Scientist – Translational Immune Oncology, Novartis. Kate Fitzgerald , Professor & Vice Chair, Department of Medicine, Division of Innate Immunity, University of Massachusetts Chan Medical School. Giulia D’Urso , Senior Clinical Scientist, Hoffmann- La Roche.

Allergies 52

Allergies Scientist Medicine Development 52

Scienmag

MARCH 4, 2021

COVID genetic mystery, power outage costs, Alzheimer pathology, optical antennas Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH Solving a Genetic Mystery at the Heart of the COVID-19 Pandemic As the COVID-19 pandemic enters its second year, scientists are still working to understand how the new strain (..)

Allergies 55

Allergies Genetics Scientist Medicine 55

Scienmag

OCTOBER 6, 2020

Scientists in the US and UK publish first in-depth look at how CD4+ T cells fight SARS-CoV-2 Credit: NIAID LA JOLLA–As scientists around the world develop life-saving COVID-19 vaccines and therapies, many are still wondering exactly why the disease proves deadly in some people and mild in others.

Scientist 40

Scientist Vaccination Vaccine Development 40

Scienmag

JANUARY 11, 2021

Scientists reach new milestone in vaccine development for neglected tropical disease Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

Scientist 40

Scientist Vaccination Vaccine Development 40

Scienmag

MAY 3, 2021

Researchers who elucidated key functions of RNA, the workhorse molecule of cells, will be honored in October The 2021 Warren Alpert Foundation Prize has been awarded to scientists Lynne Maquat and Joan Steitz for seminal discoveries in the biology and function of RNA, the workhorse molecule of cells.

RNA 41

RNA Scientist Research Allergies 41

Drug Discovery World

JANUARY 31, 2024

As such, the SLAS award opportunities, such as the SLAS Tony B Travel Award Program and the Student Poster Award, show the organisation’s commitment to providing a platform from the very beginning of a researcher or scientist’s career, as well as the importance of keeping new ideas pride of place.

Gene Therapy 52

Gene Therapy Allergies Scientist Gene 52

Scienmag

MARCH 23, 2021

of Energy Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce. Published in the Journal of Medicinal Chemistry, the research provides key […].

Drugs 68

Drugs Scientist Medicine Research 68

Scienmag

FEBRUARY 25, 2021

Research from the California Institute of Technology shows exactly how antibodies stick to and block the Zika virus, which will inform vaccine development Credit: Image courtesy of Shannon Esswein.

Antibody 52

Antibody Scientist Vaccination Vaccine 52

Scienmag

AUGUST 14, 2020

Finding could lead to genetic tests that identify infants at risk for the disease Credit: NIAID WHAT: New research supported by the National Institutes of Health delineates how two relatively common variations in a gene called KIF3A are responsible for an impaired skin barrier that allows increased water loss from the skin, promoting the development (..)

Genetics 52

Genetics Scientist Gene Development 52

Scienmag

JUNE 2, 2021

Writing in the Journal of the Royal Society of Medicine, a group of population health, demographic, epidemiology and behavioural scientists propose an approach focused on confidence, complacency, convenience, communication and […].

Vaccination 46

Vaccination Vaccine Scientist Medicine 46

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.

Drugs 52

Drugs Allergies Cardiology Drug Delivery 52

XTalks

SEPTEMBER 8, 2020

“Our experience in drug product fill/finish will enable timely manufacturing to make the vaccine available as soon as possible to advance bringing life-changing medicines to market.”. AstraZeneca, a UK-based global pharmaceutical company, is leading the COVID-19 trial as a regulatory sponsor. Fauci, in a statement.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

VirTrial

FEBRUARY 28, 2024

Meet the Experts Anthony Everhart, MD, FACP , is the internal medicine leader at Signant. Dr. Everhart is board-certified in internal medicine and a fellow of the American College of Physicians with over 23 years of experience in the practice of medicine and over 12 years of experience in clinical development.

Development 52

Development Drugs Trials Clinical Development 52

Scienmag

FEBRUARY 15, 2021

15, 2021 – By capitalizing on a convergence of chemical, biological and artificial intelligence advances, University of Pittsburgh School of Medicine scientists have developed an unusually fast and efficient method for discovering tiny antibody fragments with big potential for development into therapeutics against deadly diseases.

Antibody 40

Antibody Scientist Medicine Development 40

Scienmag

APRIL 22, 2021

SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Researchers have identified another potential target for neutralizing antibodies on the SARS-CoV-2 Spike protein that is masked by metabolites in the blood.

Antibody 46

Antibody Protein Scientist Research 46

Scienmag

NOVEMBER 2, 2020

2, 2020 – University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19. Credit: UPMC PITTSBURGH, Nov.

Antibody 40

Antibody Scientist Medicine Allergies 40

Pharma Marketing Network

APRIL 27, 2021

Rod joined Pfizer in Sandwich, UK as a Research Scientist and conducted medicinal chemistry research in the cardiovascular, GI, Sexual Health, Urology and Allergy & Respiratory diseases. Rod is the co-inventor of darifenacin (Enablex ).

Medicine 52

Medicine Allergies Research Development 52

Scienmag

OCTOBER 20, 2020

The findings open up a new front in the war on disease-causing microbes, with possible relevance to COVID-19 LA JOLLA, CA–Scientists at Scripps Research have uncovered an important disease-fighting role for cells called hepatocytes, which constitute most of the liver. According to […].

Scientist 40

Scientist Medicine Development Research 40

Scienmag

JULY 14, 2021

Scientists report that the alternative-splicing regulator NSrp70 influences immune T cell development Credit: Gwangju Institute of Science & Technology T lymphocytes, or T cells, are immune cells with diverse roles in building the body’s immunity. How does one particular cell type fight against a host of different pathogens?

Regulation 98

Regulation Scientist Development Allergies 98

Scienmag

MAY 26, 2021

Credit: HKUST In a new study, scientists at The Hong Kong University of Science and Technology (HKUST) have revealed that most T cell epitopes known to be targeted upon natural infection are seemingly unaffected by current SARS-CoV-2 variants.

Scientist 96

Scientist Research Allergies Vaccination 96

Scienmag

SEPTEMBER 14, 2020

Thanks to the sniffling noses, coughs, and colds that accompany the colder months of the year, we are all too familiar with the seasonal patterns of some respiratory viruses.

Scientist 42

Scientist Allergies Vaccination Vaccine 42

Scienmag

JANUARY 21, 2021

The year 2021 marks the 100th anniversary of a fundamental discovery that’s taught in every biochemistry textbook.

Scientist 45

Scientist Allergies Medicine 45

Scienmag

MARCH 29, 2021

– New research led by scientists at Washington State University has found that a protein known as GBP5 appears to play a key role in suppressing inflammation in rheumatoid arthritis, a potentially debilitating disease in which the immune system mistakenly attacks the […].

Protein 88

Protein Scientist Research Allergies 88

pharmaphorum

FEBRUARY 16, 2022

The scientists stress that this is not a feasible treatment for most people with HIV, as a stem cell transplant can be a dangerous medical procedure that is only used for people with life-threatening conditions. The second man from London has now been in HIV remission for more than 30 months. Dr. Anthony Fauci, who has led the U.S.

Gene Editing 67

Gene Editing Research Gene Genetics 67

Bioengineer

JULY 15, 2021

associate professor of human oncology in the University of Wisconsin School of Medicine and Public Health, and their colleagues designed a study to give mice with immunologically cold metastatic cancers varying doses of targeted radionuclide therapy alongside immunotherapy. About the University of Pittsburgh School of Medicine.

Medicine 52

Medicine Clinical Trials Clinical Trials Scientist 52

Scienmag

AUGUST 9, 2020

Credit: Phil Jones, Senior Photographer, Augusta University When the eye isn’t getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists have identified new points where they may be able to calm […]. (..)

Scientist 96

Scientist Production Allergies Medicine 96

Scienmag

JANUARY 24, 2021

(January 25, 2021) – Immediately after a traumatic brain injury and as long as one year later, there are increased levels of immune cells called ILCs in the brain promoting inflammation, which can worsen brain damage, scientists report. They also report for the first time that the […].

Scientist 86

Scientist Allergies Medicine 86

Scienmag

DECEMBER 4, 2020

LJI scientists get first glimpse of how mysterious particles break off of immune cells Credit: Alex Marki, Ph.D., The scientists are the first to show that these […].

Research 55

Research Scientist Allergies Medicine 55

Scienmag

MARCH 17, 2021

Credit: Georgia State University ATLANTA–Dr.

Scientist 59

Scientist Development Allergies Medicine 59

Scienmag

AUGUST 4, 2020

Credit: Henry Ford Health System Findings from a research study, led by scientists at Henry Ford, published in the latest issue of Nature Communications suggest an enzyme could play an important role in the treatment of cancer and autoimmune diseases in the airway.

Gene Expression 82

Gene Expression Gene Scientist Research 82

Scienmag

MARCH 2, 2021

Scientists map the degradation of antibiotic resistance gene mecA by common disinfectants to find ways to minimize the spread of resistance in waterbodies Credit: Environmental Science and Technology For nearly a century, improvement in human healthcare has depended heavily on the efficiency with which we can treat bacterial diseases.

Gene 73

Gene Scientist Allergies Medicine 73

Scienmag

MAY 12, 2021

Scripps Research scientists propose an innovative vaccine approach to protect against a troublesome family of viruses that present a major global health risk LA JOLLA, CA–Scientists at Scripps Research have unveiled a new Ebola virus vaccine design, which they say has several advantages over standard vaccine approaches for Ebola and related viruses (..)

Vaccination 47

Vaccination Vaccine Antibody Scientist 47

The Pharma Data

DECEMBER 30, 2020

Unfortunately, it has taken over 1800 years for modern medicine to really take note of his profoundly accurate insightfulness. Scientists now know that this microbiome is critical to our overall well-being. Two thousand years ago, a wise man called Hippocrates proclaimed that “All diseases begin in the gut”.

Bacteria 52

Bacteria Insulin Allergies Doctors 52

Scienmag

DECEMBER 15, 2020

From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated […]. Data analysis offers comparison of the 2 viruses Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month.

Scientist 75

Scientist Allergies Cardiology Medicine 75